Zhong Wang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Cell Proliferation

Top Venues

Cancer biology & therapy

Cell death & disease

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hanpu Zhang, Chenyuan Li, Shichong Liao, Yi Tu, Shengrong Sun, Feng Yao, Zhiyu Li, Zhong Wang
PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer. Cancer biology & therapy 23 (1) (2022)
Zhiyu Li, Chenyuan Li, Qi Wu, Yi Tu, Changhua Wang, Xin Yu, Bei Li, Zhong Wang, Si Sun, Sheng-Rong Sun
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway. Cell death & disease 12 (1) (2021)
Fuyang Chen, Wenwu Sun, Shengrong Sun, Zhiyu Li, Zhong Wang, Li Yu
Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clinical and translational medicine 10 (2) (2020)